LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
All content for i3 Health Podcast is the property of i3 Health and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
Redefining Hope in ALS: A Webinar Preview With Richard S. Bedlack, MD, PhD, MS
i3 Health Podcast
4 minutes 45 seconds
6 months ago
Redefining Hope in ALS: A Webinar Preview With Richard S. Bedlack, MD, PhD, MS
Join us for a special live webinar, Slowing Disease Progression and Optimizing Quality of Life for Patients With ALS, on Wednesday, June 11th at 1:00 pm Eastern. In this exclusive event, Dr. Richard S. Bedlack will share his expertise and latest insights on ALS care.
In this preview interview, Dr. Bedlack discusses his unique approach to supporting patients, including his innovative "Stitching Strength" philosophy, and highlights new research on hope-boosting instruments for people living with ALS. He also offers a glimpse into the key topics and messages he’ll be covering during the webinar, all aimed at helping clinicians and caregivers slow disease progression and enhance quality of life for their patients.
Don’t miss this opportunity to learn from one of the leading voices in ALS care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you on June 11th!
Click here to register now: https://bit.ly/3Zjb8wm
i3 Health Podcast
LAST CHANCE – Expires November 21!
Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.
Listen now and earn 0.5 CME credit: bit.ly/49GyP5T
